Glaucoma Clinical Research Study

Travoprost Intraocular Implant Clinical Study

If you have been told by your eye doctor that you have glaucoma or high eye pressure, you may be able to participate in this clinical study.

A tiny medical product called the Travoprost Intraocular Implant is being tested in an investigational study to help alleviate high eye pressure. The goal of the Travoprost Intraocular Implant is to lower your eye pressure (intraocular pressure or IOP). The Travoprost Intraocular Implant slowly releases Travoprost, the active drug in a commonly used glaucoma eyedrop. Travoprost is believed to increase the fluid flowing out of the front part of your eye.

Travoprost Intraocular Implant is tiny. This implant is made of titanium and is so small you won’t be able to feel it after the procedure is done. The Travoprost Intraocular Implant is one of the smallest medical products known to be placed in the human body.

About the Travoprost Intraocular Implant placement procedure

The Travoprost Intraocular Implant procedure consists of inserting an implant through a small opening in your eye. The implant is placed in a fixed location inside the eye, gradually releasing an IOP-lowering drug with the goal of lowering eye pressure long term without the use of eye drops.

Patient Participation Benefits

• Thorough Screening Evaluations
• Paid follow-up visits for up to 3 years
• Reimbursement for costs related to time and travel
• Access to promising treatments that are unavailable to the general public.
• Helping to further the advancement of glaucoma treatments.

Ophthalmologists Participating in the Trial

Learn More

If you are interested in learning more, please contact our Clinical Research Department at 678-803-2600.

Clinical Trial Sponsor

To see the official website of the clinical trial sponsor, please visit this site:

www.GlaukosClinicalTrials.com